ASHLEY LAMONICA: Open Payments
NPI 1316777279 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 63 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $404 |
| AstraZeneca Pharmaceuticals LP | 9 | $167 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| ALK-Abello, Inc | 4 | $80 |
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 4 | $78 |
| PFIZER INC. | 3 | $72 |
| Optinose US, Inc. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Amgen Inc. | 2 | $28 |
Products named: QULIPTA, VRAYLAR, MOUNJARO, Xhance, XIFAXAN, AIRSUPRA, BREZTRI, SHINGRIX.
Industry payments across NY — which companies pay providers there.
